- Login required
- As we cautioned, the Edwards Sapien valve is not launching well
- FDA streamlines risky medical device approval via 510K despite safety concerns
- Downside risk to Edwards Lifesciences estimates
- How many Sapien valves did Edwards sell in Q4?
- Key questions to ask of Edwards Lifesciences at JP Morgan
- Login required to view these stories
- Why News Corp and Disney should merge: A perfect storm is on the way for cable TV
- Was the Plan B fiasco intentional?
- Is your analyst lazy or incompetent?
- 2011 was the year people went insane in public caused by substance abuse
- It's tough to interview a dead woman: The Avastin breast cancer saga
- WSJ: Facebook FTC compaint over privacy violations
- Fox Business Are expert consulting networks legal?
- The O'Reilly Factor: Radiation risks
- Johns Hopkins News: The Dean discusses ACOs
- Reuters: Interview with FDA Commissioner
- Reuters: Mark Schoenebaum
- WSJ: Arena receives CR letter on lorcaserin
- WSJ: Arena Pharma and threats to FDA doctors
- NPR new ways to implant aortic valves
- Fox Business, weight loss drugs
- UHealth Miami Summit on Healthcare Spending reduction
- Cancerwise: The HCC Interview with Dr. Mendelsohn
- NY Department of Health advisory (reference section)
- Georegtown Legal Center blog: Professor Barnett
- Forbes: Bill Clintons stent
- NPR on the Crestor JUPITER indication approval
- NPR on changes at the FDA with medical devices
- CNBC coverage of ARBITER HALTS trial
- Scientific American: Unsustainable cancer drug costs
- Fox Business: Doctors should be paid more
- Congressional Health Care Caucus
- Center for Health Transformation
- Fox Business: What to monitor with swine flu
- WSJ.com: The JUPITER trial
- Fox Business: FTC scrutiny of the PFE WYE merger
- The Wall Street Journal: Avastin for Breast Cancer
- WSJ.com: video tutorial on dermal fillers and Botox
- Fox Business: Health of Healthcare
- The Wall Street Journal: Senator Grassley
- The Wall Street Journal: Knee arthroscopy of no benefit in o
- The Wall Street Journal: JNJ DTC TV ads on Cypher
- The Wall Street Journal: Vytorin May Lose Preferred Medicare
- ABC News: Steve Jobs of Apple and his cancer
- The Wall Street Journal: Senate Inquiry into ACC and CRF
- The Wall Street Journal: Liposuction with Dr. Fodor
- The Wall Street Journal: the Next Biotech to be Acquired?
- The Wall Street Journal: The Tysabri Re-Launch
- The Wall Street Journal: Who is Dr. Jarvik Anyway?
- The Wall Street Journal: ASCO abstracts story
- The Wall Street Journal: Avastin for Brain Cancer